Literature DB >> 17178762

Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.

K Fujikawa, K Aratake, A Kawakami, T Aramaki, N Iwanaga, Y Izumi, K Arima, M Kamachi, M Tamai, M Huang, H Nakamura, Y Nishiura, T Origuchi, H Ida, K Eguchi.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17178762      PMCID： PMC1798413          DOI： 10.1136/ard.2006.056804

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Transcranial magnetic stimulation in Behçet's disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findings.

Authors:  B Stigsby; S Bohlega; D R McLean; M Z Al-Kawi
Journal:  Clin Neurophysiol       Date:  2000-07       Impact factor: 3.708

Review 2.  The innate immune system in rheumatoid arthritis.

Authors:  W P Arend
Journal:  Arthritis Rheum       Date:  2001-10

3.  Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

Authors:  G Licata; A Pinto; A Tuttolomondo; A Banco; F Ciccia; A Ferrante; G Triolo
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

Review 4.  Cytokine therapy in rheumatoid arthritis.

Authors:  J Hermann; M Walmsley; F M Brennan
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Neuro-Behçet disease. A review.

Authors:  Afshin Borhani Haghighi; Rahman Pourmand; Ali-Reza Nikseresht
Journal:  Neurologist       Date:  2005-03       Impact factor: 1.398

6.  Successful treatment of long-standing neuro-Behçet's disease with infliximab.

Authors:  Haroon Sarwar; Hugh McGrath; Luis R Espinoza
Journal:  J Rheumatol       Date:  2005-01       Impact factor: 4.666

7.  Cytokine production profile in patients with Behcet's disease treated with infliximab.

Authors:  Midori Misumi; Eri Hagiwara; Mitsuhiro Takeno; Yukiko Takeda; Yuko Inoue; Takashi Tsuji; Atsuhisa Ueda; Satoshi Nakamura; Shigeaki Ohno; Yoshiaki Ishigatsubo
Journal:  Cytokine       Date:  2003-12-07       Impact factor: 3.861
  7 in total
  13 in total

Review 1.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 2.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

Review 3.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

4.  Longitudinal Myelitis of a Neuro-Behçet Patient.

Authors:  Qi Tang; Jing Tian
Journal:  Arch Rheumatol       Date:  2015-11-03       Impact factor: 1.472

Review 5.  The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.

Authors:  Aksel Siva; Sabahattin Saip
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

6.  Behçet's disease in black skin. A retrospective study of 50 cases in Dakar.

Authors:  Maodo Ndiaye; Aboubacary Sadikh Sow; Abbaspour Valiollah; Moussa Diallo; Assane Diop; Rachidi Amal Alaoui; Boubacar Ahy Diatta; Fatimata Ly; Suzanne Oumou Niang; Mame Thierno Dieng; Assane Kane
Journal:  J Dermatol Case Rep       Date:  2015-12-31

7.  Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.

Authors:  Shunsei Hirohata; Hirotoshi Kikuchi; Tetsuji Sawada; Hiroko Nagafuchi; Masataka Kuwana; Mitsuhiro Takeno; Yoshiaki Ishigatsubo
Journal:  Mod Rheumatol       Date:  2011-09-21       Impact factor: 3.023

Review 8.  Recent understanding on diagnosis and management of central nervous system vasculitis in children.

Authors:  Ludovico Iannetti; Roberta Zito; Simone Bruschi; Laura Papetti; Fiorenza Ulgiati; Francesco Nicita; Francesca Del Balzo; Alberto Spalice
Journal:  Clin Dev Immunol       Date:  2012-09-12

Review 9.  Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.

Authors:  Seema Kalra; Alan Silman; Gulsen Akman-Demir; Saeed Bohlega; Afshin Borhani-Haghighi; Cris S Constantinescu; Habib Houman; Alfred Mahr; Carlos Salvarani; Petros P Sfikakis; Aksel Siva; Adnan Al-Araji
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

10.  Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Authors:  Toshifumi Hibi; Shunsei Hirohata; Hirotoshi Kikuchi; Ukihide Tateishi; Noriko Sato; Kunihiko Ozaki; Kazuoki Kondo; Yoshiaki Ishigatsubo
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.